Term
|
Definition
Tomolol
B blocker (nonselective) |
|
|
Term
|
Definition
carteolol
B blocker (NSBA) |
|
|
Term
|
Definition
Levobunolol
B blocker (NSBA) |
|
|
Term
|
Definition
betaxolol
B blocker (Selective)
|
|
|
Term
|
Definition
lovobetaxolol
B blocker (selective) |
|
|
Term
|
Definition
Acetazolamide
carbonic nahydrase inhibitor |
|
|
Term
|
Definition
dorozlamide
carbonic anhydrase inhibitor |
|
|
Term
|
Definition
brinzolamide
carbonic anhydrase inhibitor |
|
|
Term
|
Definition
methazolamide
carbonic anhydrase inhibitor |
|
|
Term
|
Definition
latanoprost
prostaglandin analog |
|
|
Term
|
Definition
bimatoprost
prostaglandin analog |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Decrease in aqueous humor formation |
|
|
Term
|
Definition
| Increase in aqueous humor outflow |
|
|
Term
MOA
carbonic hydrase inhibitor |
|
Definition
| Decrease in aqueous humor formation |
|
|
Term
MOA
Prostaglandin analogs |
|
Definition
| Increase uveoscleral outflow |
|
|
Term
|
Definition
| decrease in aqueous humor formation |
|
|
Term
|
Definition
125, 250mg tab
500mg ER cap |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
